YouTube Facebook LinkedIn Google+ Twitter Xingrss  

FDA Requires Review of Personal Genomics Kits


June 14, 2010 | The FDA sent letters to 23andMe, Navigenics, deCODE Genetics, Illumina, and Knome on Friday explaining that the companies' consumer genomics kits should be reviewed under the same process used for medical devices. The FDA will decide after review if the products can remain on the market. San Francisco Chronicle 

View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.